C Rad (CRAD B.ST) Azione Prezzo
C Rad Prezzo
Negli ultimi 17 anni C Rad ha aumentato il fatturato del 41,0% all'anno, raggiungendo 441,90 Mio. SEK. L'utile per azione è diminuito del 10,7% all'anno negli ultimi 7 anni. Per C Rad, il margine netto del 2,4% risulta in calo rispetto al 9,6% di alcuni anni fa. Il target di prezzo di consenso a 12 mesi per C Rad è 44,88 SEK, circa il 57,5% sopra il prezzo attuale di mercato. Su 5 analisti, 4 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
C Rad Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
C Rad Azione e analisi azionaria
Domande frequenti sull'azione C Rad
The business model of C Rad AB is focused on providing innovative and advanced medical imaging solutions. C Rad AB is a company that specializes in developing and selling products for the radiation therapy market. They offer a range of solutions including advanced imaging tools and software designed to enhance the accuracy and efficiency of radiation therapy treatments. With a strong commitment to research and development, C Rad AB aims to provide healthcare professionals with cutting-edge technology that improves patient outcomes.
C Rad AB is primarily active in the medical technology industry.
The main competitors of C Rad AB in the market include Elekta AB, Varian Medical Systems Inc., and Accuray Incorporated.
C Rad AB is a Swedish medical technology company that specializes in innovative solutions for cancer treatment. Founded in 2004, C Rad AB has a rich history of developing advanced products for radiation therapy. With a strong focus on improving patient care, the company offers cutting-edge solutions like the C-RAD Catalyst system, which enhances accuracy and efficiency in radiotherapy. The company's commitment to research and development has made C Rad AB a trusted name in the field of oncology. With a vision to revolutionize cancer treatment, C Rad AB continues to make significant contributions to the medical industry through its state-of-the-art technologies and solutions.
C Rad AB has achieved several significant milestones since its inception. The company successfully developed innovative medical solutions, focusing on advanced imaging systems for radiation therapy. C Rad AB has gained notable recognition for its cutting-edge technologies and has received various awards for its exceptional contributions to the field. Additionally, the company has achieved significant collaborations with leading medical institutions and established a global presence by expanding its operations into multiple countries. C Rad AB continues to push boundaries, providing state-of-the-art solutions that enhance precision and safety in radiation therapy treatments.
C Rad AB is primarily present in Sweden.
C Rad AB represents values such as innovation, quality, and sustainability. As a company, C Rad AB is committed to delivering cutting-edge technology and solutions in the field of advanced radiation therapy. With a focus on developing and commercializing innovative products, C Rad AB aims to improve cancer treatment outcomes and enhance patient care. The company's corporate philosophy revolves around continuous research and development, collaboration with healthcare professionals, and a customer-centric approach. C Rad AB strives to make a positive impact on society by providing state-of-the-art solutions that contribute to the advancement of cancer care.
Gli analisti fissano attualmente un prezzo obiettivo medio di 44,88 SEK per l’azione C Rad (mediana: 44,88 SEK), pari a +57,5 % rispetto all’ultimo prezzo. Il consenso si basa su 5 giudizi di analisti.
5 analisti valutano attualmente l’azione C Rad: 4 raccomandano l’acquisto, 1 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per C Rad ricavi pari a 463,88 Mio. SEK e un utile per azione di 2,28 SEK.
Convertita al tasso di cambio attuale, l’azione C Rad quota 2,56 EUR (28,50 SEK).
L’azione C Rad (CRAD B.ST) è quotata su 4 borse, tra cui: London (0R44.L), Frankfurt (24C.F), Stockholm (CRAD B.ST).
The company C Rad AB is a leading provider of digital radiology and medical technology solutions. The company offers a wide range of products and services tailored to the needs of patients, doctors, and hospitals. One of the core divisions of C Rad AB is the development and manufacture of digital radiology systems, including Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and digital X-ray systems. These systems are capable of creating precise images of tissues and organs while enabling minimally invasive treatments. C Rad AB aims to improve patient care by focusing on the development of systems that enable precise and fast diagnoses. Another important business area is the development of medical software solutions. C Rad AB has developed a range of tools for digitally capturing, archiving, and analyzing radiological images. These analysis tools allow radiologists to make fast diagnoses and plan effective treatments. The software solutions also include a platform for data exchange and collaboration, making it easier for doctors and clinics to share patient images and data. C Rad AB also operates a number of diagnostic centers that offer a comprehensive range of health services. These centers provide rapid tests, radiology services, laboratory diagnostics, and other medical services. The centers are equipped with state-of-the-art technology and provide fast and accurate diagnoses for patients. Finally, C Rad AB also offers a variety of training and support services for patients and medical professionals. The company operates its own training academy, offering training for radiologists and medical personnel. Additionally, the company provides technical support and maintenance services for its products. Overall, the business model of C Rad AB is focused on offering innovative solutions for radiology and digital medicine. The company has a strong research and development department that is constantly working on new technologies and solutions. By combining top-quality products, services, and training, C Rad AB has strengthened its position as a leading provider of medical technology solutions.
Il attesa fatturato di C Rad ammonta a 463,88 Mio. SEK. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di C Rad ammonta a 77,23 Mio. SEK. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di C Rad è attualmente 12,47. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione C Rad.
Il rapporto prezzo/fatturato (P/S) di C Rad è attualmente 2,08. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione C Rad.
Il Quality Score AlleAktien per C Rad è 5/10.
L'ISIN di C Rad è SE0002016352. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di C Rad è A0X93X. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di C Rad è CRAD B.ST. Con questo simbolo di borsa vengono negoziate le azioni C Rad in borsa.
Azione C Rad
Gruppo di pari di C Rad
C Rad Ticker
C Rad FIGI
Altre metriche e analisi di C Rad in Deep Dive.
La nostra analisi azionaria dell'azione C Rad include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di C Rad. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: